TRNS
Transcat, Inc.
NASDAQ · Industrials · Industrial - Distribution · US
$85.48
−0.25%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
43.3x
EV/EBITDA
24.1x
Market Cap
$800.08M
MomentumView details →
1D Return
−0.25%
YTD Return
+51.22%
RSI (14)
42.5
ValuationView details →
P/E (Fwd)
43.3x
EV/EBITDA
24.1x
Market Cap
$800.08M
RSI (14)
42.5
MomentumView details →
1D Return
−0.25%
YTD Return
+51.22%
SummaryUpdated Jun 1, 2026
Transcat, Inc. (NASDAQ:TRNS) is a Rochester, New York-based industrial services company that was incorporated in 1964 and went public in 1977. The company has evolved from its origins into a specialized provider of calibration services and test equipment distribution, primarily serving highly regulated industries such as life sciences, aerospace, and defense. Over nearly six decades, Transcat has grown through both organic expansion and strategic acquisitions, establishing itself as a leading player in the precision measurement and calibration industry across the United States, Canada, and internationally.
Similar companies
Latest newsMore news →
Transcat, Inc. acquired Southeastern Biomedical, expanding its biomedical calibration channel.4d agoTranscat, Inc. reported quarterly earnings of $0.51 per share for the quarter ended June 2026, beating the Zacks Consensus Estimate of $0.37 per share, and compared to $0.59 per share a year earlier.31d agoTranscat Inc reported its Q1 FY2027 financial results with total consolidated revenue of $92.945 million, GAAP net income of $1.331 million, and diluted EPS of $0.14.32d ago